Ilhan O - Search Results

1

In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia.

Ustün C, Beksac M, Dalva K, Koc H, Konuk N, Ilhan O, Ozcan M, Topcuoglu P, Sertkaya D, Hayran M. Ustün C, et al. Among authors: ilhan o. Med Oncol. 2002;19(1):59-67. doi: 10.1385/MO:19:1:59. Med Oncol. 2002. PMID: 12025892

2

Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia.

Beksaç M, Arslan O, Koç H, Akan H, Ilhan O, Arat M, Ozcan M, Gürman G, Konuk N, Uysal A. Beksaç M, et al. Among authors: ilhan o. Med Oncol. 1998 Sep;15(3):183-90. doi: 10.1007/BF02821937. Med Oncol. 1998. PMID: 9819795 Clinical Trial.

3

P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.

Beksaç M, Akan H, Koç H, Ilhan O, Ertürk S, Güneyli A, Ikizünal Y, Sardaş OS. Beksaç M, et al. Among authors: ilhan o. Med Oncol Tumor Pharmacother. 1992;9(2):101-5. Med Oncol Tumor Pharmacother. 1992. PMID: 1364132

4

The clinical correlations of serum tumor necrosis factor-alpha in acute leukemias: a predictor of response and relapse?

Beksaç M, Ertürk S, Akan H, Koç H, Ilhan O. Beksaç M, et al. Among authors: ilhan o. Leukemia. 1993 Nov;7(11):1773-6. Leukemia. 1993. PMID: 8231245

5

Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey.

Ilhan O, Akan H, Koç H, Gürman G, Arslan O, Ozcan M, Erdi H, Erdem C, Konuk N, Uysal A, Beksaç M. Ilhan O, et al. Hematol Cell Ther. 1997 Jun;39(3):133-6. doi: 10.1007/s00282-997-0133-1. Hematol Cell Ther. 1997. PMID: 9262989

6

Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support.

Koç H, Arslan O, Gürman G, Akan H, Ozcan M, Ilhan O, Aydoğdu I, Arat M, Beksaç M, Konuk N, Uysal A. Koç H, et al. Among authors: ilhan o. Acta Haematol. 1997;98(3):136-9. doi: 10.1159/000203607. Acta Haematol. 1997. PMID: 9352743 Clinical Trial.

7

Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?

Koç H, Gürman G, Arslan O, Ozcan M, Dilek I, Akan H, Ilhan O, Konuk N, Beksaç M, Uysal A. Koç H, et al. Among authors: ilhan o. J Chemother. 1997 Oct;9(5):371-6. doi: 10.1179/joc.1997.9.5.371. J Chemother. 1997. PMID: 9373793 Clinical Trial.

8

Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma.

Aydogdu I, Koc H, Ilhan O, Gurman G, Akan H, Beksac M, Konuk N, Uysal A, Ozerol E. Aydogdu I, et al. Among authors: ilhan o. Haematologia (Budap). 1997;28(4):207-13. Haematologia (Budap). 1997. PMID: 9408764

9

Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.

Dilek I, Demirer T, Ustün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Ozcan M, Ilhan O, Akan H. Dilek I, et al. Among authors: ilhan o. Bone Marrow Transplant. 1998 Jun;21(11):1159-61. doi: 10.1038/sj.bmt.1701240. Bone Marrow Transplant. 1998. PMID: 9645582

10

Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey.

Arslan O, Gürman G, Dilek I, Ozcan M, Koç H, Ilhan O, Akan H, Konuk N, Uysal A, Beksaç M. Arslan O, et al. Among authors: ilhan o. Haematologia (Budap). 1998;29(1):59-62. Haematologia (Budap). 1998. PMID: 9704259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters